mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0006 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.001 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.001 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |